• Je něco špatně v tomto záznamu ?

Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells

K. Kratochvílová, P. Horak, M. Ešner, K. Souček, D. Pils, M. Anees, E. Tomasich, F. Dráfi, V. Jurtíková, A. Hampl, M. Krainer, P. Vaňhara,

. 2015 ; 137 (6) : 1330-40. [pub] 20150321

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031442

Ovarian cancer is one of the most common malignancies in women and contributes greatly to cancer-related deaths. Tumor suppressor candidate 3 (TUSC3) is a putative tumor suppressor gene located at chromosomal region 8p22, which is often lost in epithelial cancers. Epigenetic silencing of TUSC3 has been associated with poor prognosis, and hypermethylation of its promoter provides an independent biomarker of overall and disease-free survival in ovarian cancer patients. TUSC3 is localized to the endoplasmic reticulum in an oligosaccharyl tranferase complex responsible for the N-glycosylation of proteins. However, the precise molecular role of TUSC3 in ovarian cancer remains unclear. In this study, we establish TUSC3 as a novel ovarian cancer tumor suppressor using a xenograft mouse model and demonstrate that loss of TUSC3 alters the molecular response to endoplasmic reticulum stress and induces hallmarks of the epithelial-to-mesenchymal transition in ovarian cancer cells. In summary, we have confirmed the tumor-suppressive function of TUSC3 and identified the possible mechanism driving TUSC3-deficient ovarian cancer cells toward a malignant phenotype.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031442
003      
CZ-PrNML
005      
20151013095718.0
007      
ta
008      
151005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ijc.29502 $2 doi
035    __
$a (PubMed)25735931
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kratochvílová, Kateřina $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
245    10
$a Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells / $c K. Kratochvílová, P. Horak, M. Ešner, K. Souček, D. Pils, M. Anees, E. Tomasich, F. Dráfi, V. Jurtíková, A. Hampl, M. Krainer, P. Vaňhara,
520    9_
$a Ovarian cancer is one of the most common malignancies in women and contributes greatly to cancer-related deaths. Tumor suppressor candidate 3 (TUSC3) is a putative tumor suppressor gene located at chromosomal region 8p22, which is often lost in epithelial cancers. Epigenetic silencing of TUSC3 has been associated with poor prognosis, and hypermethylation of its promoter provides an independent biomarker of overall and disease-free survival in ovarian cancer patients. TUSC3 is localized to the endoplasmic reticulum in an oligosaccharyl tranferase complex responsible for the N-glycosylation of proteins. However, the precise molecular role of TUSC3 in ovarian cancer remains unclear. In this study, we establish TUSC3 as a novel ovarian cancer tumor suppressor using a xenograft mouse model and demonstrate that loss of TUSC3 alters the molecular response to endoplasmic reticulum stress and induces hallmarks of the epithelial-to-mesenchymal transition in ovarian cancer cells. In summary, we have confirmed the tumor-suppressive function of TUSC3 and identified the possible mechanism driving TUSC3-deficient ovarian cancer cells toward a malignant phenotype.
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a stres endoplazmatického retikula $x genetika $7 D059865
650    _2
$a epitelo-mezenchymální tranzice $x genetika $7 D058750
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a tumor supresorové geny $x fyziologie $7 D016147
650    _2
$a heterografty $7 D064593
650    _2
$a lidé $7 D006801
650    _2
$a membránové proteiny $x genetika $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    _2
$a nádory vaječníků $x genetika $7 D010051
650    _2
$a nádorové supresorové proteiny $x genetika $7 D025521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Horak, Peter $u Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Ešner, Milan $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Souček, Karel $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Pils, Dietmar $u Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
700    1_
$a Anees, Mariam $u Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan. $7 gn_A_00006828
700    1_
$a Tomasich, Erwin $u Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Dráfi, František $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Jurtíková, Veronika $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Hampl, Aleš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Krainer, Michael $u Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Vaňhara, Petr $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
773    0_
$w MED00002298 $t International journal of cancer. Journal international du cancer $x 1097-0215 $g Roč. 137, č. 6 (2015), s. 1330-40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25735931 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151013095908 $b ABA008
999    __
$a ok $b bmc $g 1092318 $s 914568
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 137 $c 6 $d 1330-40 $e 20150321 $i 1097-0215 $m International journal of cancer $n Int J Cancer $x MED00002298
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace